Fluorescence in situ hybridization, anaplastic lymphoma kinase, gene rearrangement
FDA product code OWE · Class 2 · 1 device · 1 reports · 0 devices named in recalls
- Vysis 06N38-033Abbott Molecular Inc. · Fluorescence in situ hybridization, anaplastic lymphoma kinase, gene rearrangement1 report